Chronic apelin treatment (two to four weeks) improves insulin sensitivity, lowers blood glucose levels, and protect the animals from hyperinsulinemia and glucose intolerance in mice with obesity or insulin resistance [228,230]. The gene discussed is APLN; the disease is obesity disorder.